Conference Coverage

Three days of beta-lactam beat clinically stable CAP


 

REPORTING FROM ECCMID 2018

Nor does Dr. Dinh expect wholesale clinical embracing of the encouraging results, which bolster the ever-accumulating data in favor of shorter courses of antibiotics for some infectious diseases.

“I think there is a chance that clinicians who normally treat for 9 or 10 days may now feel comfortable reducing to 7,” he said with a chuckle.

The French Ministry of Health sponsored the study. Dr. Dinh had no competing financial interests.

SOURCE: Dinh et al. ECCMID 2018, Oral Abstract O1126.

Pages

Recommended Reading

Risks identified for drug-resistant bacteremia in cirrhosis
MDedge Internal Medicine
Common food additive makes C. difficile more virulent
MDedge Internal Medicine
Drug combo indicated for bacterial pneumonia
MDedge Internal Medicine
Reported penicillin allergies hike inpatient costs
MDedge Internal Medicine
FDA warns against clarithromycin use in patients with heart disease
MDedge Internal Medicine
Unusual antibiotic resistance found in more than 200 bacteria
MDedge Internal Medicine
MDedge Daily News: Antibiotic resistance leads to ‘nightmare’ bacteria
MDedge Internal Medicine
FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic
MDedge Internal Medicine
Don’t shorten therapy for older, sicker cellulitis patients
MDedge Internal Medicine
ESBL-resistant bacteria spread in hospital despite strict contact precautions
MDedge Internal Medicine